Nutex Health Inc

Nutex Health, Inc. operates as technology-enabled healthcare services. It has two divisions: a Hospital Division and a Population Health Management Division. The company was founded in 2011 and is headquartered in Houston, TX.

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Nutex Health Inc excels in Q3 with revenue surge and strategic growth plans

Nutex Health Inc's Q3 performance reflects strong revenue growth, improved EBITDA, and enhanced operational efficiency, positioning the company for continued success.
While facing challenges such as net losses and increased lease liabilities, strategic initiatives and opportunities in hospital and population health divisions offer avenues for growth and profitability.
Efforts to remove variable interest entities from the balance sheet signal a commitment to financial restructuring and transparency, paving the way for sustained financial health and investor trust.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Nutex Health, Inc. operates technology-enabled healthcare services. It operates through the following segments: Hospital Division, Population Health Management Division, and Real State Division. The Hospital Division is involved in developing and operating a network of micro-hospitals, specialty hospitals and hospital outpatient departments providing comprehensive and high-quality 24/7 care. The Population Health Division establishes and operates independent physician associations and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real State Division includes owning a land and hospital buildings which are leased to the hospital entities The company was founded in 2011 and is headquartered in Houston, TX.

Nutex Health Inc. (NASDAQ:NUTX ) Q3 2024 Earnings Conference Call November 8, 2024 10:30 AM ET Company Participants Vivian Sanders - Corporate Director of Marketing and Business Development Tom Vo - Chairman and Chief Executive Officer Jon Bates - Chief Financial Officer Warren Hosseinion - President Josh DeTillio - Chief Operating Office Conference Call Participants Bill Sutherland - The Benchmark Company Tom McGovern - Maxim Operator Greetings, and welcome to the Nutex Health Inc. Third Quarter 2024 Financial Results Conference Call. [Operator Instructions] It is now my pleasure to introduce your host, Vivian Sanders.

Nutex Health Inc. (NUTX) Q3 2024 Earnings Call Transcript

TOTAL REVENUE OF $222.3 MILLION FOR THE FIRST NINE MONTHS OF 2024 VS. $178.0 MILLION FOR THE SAME PERIOD IN 2023, AN INCREASE OF 25% HOSPITAL DIVISION VISITS OF 122,944 FOR THE FIRST NINE MONTHS OF 2024 VS.

NUTEX HEALTH REPORTS THIRD QUARTER AND YEAR TO DATE SEPTEMBER 30, 2024 FINANCIAL RESULTS

HOUSTON , Nov. 5, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 22 state-of-the-art micro hospitals in 10 states and primary care-centric, risk-bearing physician networks, today announced that it will release financial results for the third quarter ended September 30, 2024 after the close of the stock market on Thursday, November 7, 2024. The Company will discuss those results on a conference call on Friday, November 8, 2024, at 10:30 am ET.

NUTEX HEALTH SCHEDULES 2024 THIRD QUARTER FINANCIAL RESULTS RELEASE AND CONFERENCE CALL

Shares of Nutex Health Inc (NUTX, Financial) surged 5.48% in mid-day trading on Oct 2. The stock reached an intraday high of $21.86, before settling at $21.69, up from its previous close of $20.56.

Nutex Health Inc (NUTX) Shares Up 5.48% on Oct 2

HOUSTON , Sept. 30, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 22 state-of-the-art micro hospitals in 10 states and primary care-centric, risk-bearing physician networks, today announced that Nutex Health hospitals have won multiple community-driven awards and accolades in the third quarter of 2024, reflecting the staff's commitment to excellence.

NUTEX HEALTH HOSPITALS WIN MULTIPLE AWARDS IN THE 3rd QUARTER OF 2024

Nutex Health expands its footprint with Post Falls ER & Hospital on the border of Idaho and Washington, serving patients from both states. POST FALLS, Idaho , Aug. 26, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, healthcare delivery system comprised of 22 state-of-the-art micro hospitals in 10 states and primary care-centric, risk-bearing physician networks, today announced the opening of Post Falls ER & Hospital, located at 497 S Beck Road in Post Falls, Idaho.

NUTEX HEALTH OPENS POST FALLS ER & HOSPITAL, ITS FIRST HOSPITAL IN IDAHO

Nutex Health (NASDAQ:NUTX ) Q2 2024 Earnings Conference Call August 9, 2024 10:00 AM ET Company Participants Jennifer Rodriguez - Investor Relations Manager Tom Vo - Chairman and Chief Executive Officer Jon Bates - Chief Financial Officer Warren Hosseinion – President Josh DeTillio – Chief Operating Office Conference Call Participants Bill Sutherland - The Benchmark Company Operator Greetings, and welcome to Nutex Health Second Quarter 2024 Financial Results Conference Call. At this time, all participants are on a listen-only mode.

Nutex Health (NUTX) Q2 2024 Earnings Call Transcript

TOTAL REVENUE OF $143.5 MILLION FOR THE FIRST HALF 2024 VS $115.3 MILLION FOR THE FIRST HALF 2023, AN INCREASE OF 25% HOSPITAL DIVISION VISITS OF 81,276 FOR THE FIRST HALF 2024 VS VISITS OF 65,244 FOR THE FIRST HALF 2023, AN INCREASE OF 25% HOSPITAL DIVISION OPERATING INCOME OF $33.3 MILLION FOR THE FIRST HALF 2024 VS $13.9 MILLION FOR THE FIRST HALF 2023, AN INCREASE OF 140% NET CASH FROM OPERATING ACTIVITIES OF $16.3 MILLION FOR THE FIRST HALF 2024 COMPANY CONTINUES ITS FOCUS ON INCREASING CASH FLOW HOUSTON , Aug. 8, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in nine states and primary care-centric, risk-bearing physician networks, today announced second quarter 2024 financial results for the three and six months ended June 30, 2024. Financial Highlights for the Three Months Ended June 30, 2024: Total revenue of $76.1 million as compared to total revenue of $58.9 million for the three months ended June 30, 2023, an increase of 29%.

NUTEX HEALTH REPORTS SECOND QUARTER AND SIX MONTHS ENDED JUNE 30, 2024 FINANCIAL RESULTS

HOUSTON , Aug. 5, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, today announced that it will release financial results for the second quarter ended June 30, 2024 after the close of the stock market on Thursday, August 8, 2024. The Company will discuss those results on a conference call on Friday, August 9, 2024 at 10:00 am ET.

NUTEX HEALTH SCHEDULES 2024 SECOND QUARTER FINANCIAL RESULTS RELEASE AND CONFERENCE CALL

HOUSTON, July 29, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, announced today that it has received formal notice from The Nasdaq Stock Market LLC ("Nasdaq") indicating that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market as required by the Hearing Panel's June 14, 2024 decision, as previously disclosed in the Company's Current Report on Form 8-K filed on June 18, 2024. The Nasdaq staff made this determination of compliance after the closing bid price of the Company's common stock traded above $1.00 per share from July 3, 2024, the date of the Company's 1:10 reverse stock split, to July 23, 2024.

NUTEX HEALTH REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE

HOUSTON , July 15, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in nine states and primary care-centric, risk-bearing physician networks, today announced Nutex Health hospitals won nine awards in 2024's second quarter, reflecting the staff's commitment to excellence. Nutex Health hospitals have historically served as the safety net for the communities in which we serve.

Nutex Health Hospitals Prove Patient Satisfaction with Nine Awards and Honors Earned in Q2

HOUSTON , June 27, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), today announced a 1-for-10 reverse stock split of its common stock effective with the market opening on Wednesday, July 3, 2024.  The reverse stock split will take legal effect at 11:59pm Eastern Time on July 2, 2024, and the Company's common stock will open for trading on The Nasdaq Capital Market on July 3, 2024 on a post-split basis, under the existing ticker symbol "NUTX" but with new CUSIP number 67079U306.

NUTEX HEALTH ANNOUNCES 1-FOR-10 REVERSE STOCK SPLIT

COMPANY EXPECTS TO REGAIN COMPLIANCE WITH NASDAQ'S MINIMUM BID REQUIREMENT BEFORE JULY 22, 2024 HOUSTON , June 19, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in nine states and primary care-centric, risk-bearing physician networks, announced that during its annual shareholder meeting yesterday, it obtained approval from its shareholders to effect a reverse stock split of between 1-for-2 to 1-for-16. On June 14, 2024, the Company received notice from the Nasdaq Stock Market LLC ("Nasdaq") that a Nasdaq Hearings Panel had granted the Company an exception until July 22, 2024 to effect a reverse stock split of its common stock once approved by its Board of Directors and the Company's stockholders.

NUTEX HEALTH ANNOUNCES THAT IT HAS OBTAINED APPROVAL FROM ITS SHAREHOLDERS TO EFFECT A REVERSE STOCK SPLIT

HOUSTON , May 24, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in nine states and primary care-centric, risk-bearing physician networks, today announced that it had had received a staff determination letter  on May21, 2024 from the Listing Qualifications Department  of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that, due to the Company's non-compliance with the minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Requirement"), the Company's Common Stock would be scheduled for delisting from The Nasdaq Capital Market and would be suspended for trading at the opening of business on May 30, 2024 unless the Company timely requests a hearing before an independent Nasdaq Hearings Panel (the "Panel") by May 28, 2024.  On May 23, 2024, the Company submitted a request for a hearing to appeal the Staff's delisting determination.

NUTEX HEALTH ANNOUNCES NASDAQ DELISTING NOTIFICATION AND STAY PENDING ONGOING APPEAL. NO IMMEDIATE EFFECT ON THE LISTING OR TRADING OF THE COMMON STOCK.

Nutex Health (NASDAQ:NUTX ) Q1 2024 Earnings Conference Call May 10, 2024 10:30 AM ET Company Participants Jennifer Rodriguez – Investor Relations Manager Tom Vo – Chairman and Chief Executive Officer Jon Bates – Chief Financial Officer Warren Hosseinion – President Josh DeTillio – Chief Operating Office Conference Call Participants Bill Sutherland – The Benchmark Company Operator Greetings and welcome to the Nutex Health First Quarter 2024 Financial Results Earnings Call. At this time, all participants are in a listen-only mode.

Nutex Health (NUTX) Q1 2024 Earnings Call Transcript

TOTAL REVENUE OF $67.5 MILLION FOR FIRST QUARTER 2024 VS $56.3 MILLION IN 2023, AN INCREASE OF 20% HOSPITAL DIVISION VISITS OF 40,068 FOR THE FIRST QUARTER 2024 VS VISITS OF 33,085 IN 2023, AN INCREASE OF 21.1% HOSPITAL DIVISION OPERATING INCOME OF $10.5 MILLION FOR FIRST QUARTER 2024 VS $4.8 MILLION IN 2023, AN INCREASE OF 119% NET CASH FROM OPERATING ACTIVITIES OF $3.1 MILLION FOR FIRST QUARTER 2024 CONTINUED FOCUS ON INCREASED CASH FLOW THROUGH REDUCTION IN OPERATING EXPENSES AND PORTFOLIO OPTIMIZATION HOUSTON , May 8, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in nine states and primary care-centric, risk-bearing physician networks, today announced first quarter 2024 financial results for the three months ended March 31, 2024. Financial Highlights for the Three Months Ended March 31, 2024: Total revenue of $67.5 million as compared to total revenue of $56.3 million for the three months ended March 31, 2023, an increase of approximately 20%.

NUTEX HEALTH REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

HOUSTON , May 7, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, today announced that it will release financial results for the first quarter ended March 31, 2024 after the close of the stock market on Wednesday, May 8, 2024. The Company will discuss those results on a conference call on Friday, May 10, 2024 at 10:30am ET.

NUTEX HEALTH SCHEDULES 2024 FIRST QUARTER FINANCIAL RESULTS RELEASE AND CONFERENCE CALL

HOUSTON , May 6, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, today announced the availability of its definitive proxy materials for its 2024 Annual Meeting to be held on June 17, 2024 at 10:00 am Central Daylight Time via the internet as a virtual meeting only (and not in person) at www.virtualshareholdermeeting.com/NUTX2024. We look forward to hosting you at our virtual shareholder meeting and encourage you to participate and vote.

NUTEX HEALTH ANNOUNCES INTERNET AVAILABILITY OF PROXY MATERIALS FOR ITS 2024 ANNUAL MEETING

HOUSTON , April 29, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, today announced its second annual private leadership conference from April 30 to May 2 in Houston, Texas.    The conference serves as an opportunity for Nutex Health leaders from across the country to gather, strategize and execute new and old business initiatives.

NUTEX HEALTH HOSTS SECOND ANNUAL INTERNAL LEADERSHIP CONFERENCE

HOUSTON , April 22, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, today announced the appointment of Scott J. Saunders, and Kelvin Spears, MD, to its Board of Directors.

NUTEX HEALTH ANNOUNCES CHANGES TO ITS BOARD OF DIRECTORS

HOUSTON , April 16, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, today announced Nutex hospitals have won seven awards and four recognitions in the first quarter of 2024, reflecting the staff's commitment to excellence. Nutex Health hospitals have historically served as the safety net for the communities in which we serve.

Nutex Health Hospitals Gain Community Recognition and Take Home Seven Patient Satisfaction Awards in Q1

COMPANY IS ADVANCING ITS ONGOING STRATEGIC PLAN DESIGNED TO SIGNIFICANTLY REDUCE COSTS, REACH POSITIVE NET INCOME AND IMPROVE CASH FLOW HOUSTON , April 12, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, today provides a corporate update. As of April 11, 2024, the Company had cash and cash equivalents of approximately $25 million (unaudited).

NUTEX HEALTH PROVIDES CORPORATE UPDATE

Nutex Health expands its footprint in the northern US with its first hospital in Wisconsin. HOUSTON , April 8, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, today announced the opening of Green Bay ER & Hospital, located at 2465 Monroe Road in Bellevue, Wisconsin.

NUTEX HEALTH OPENS FIRST HOSPITAL OF 2024 IN BELLEVUE, WISCONSIN

Nutex Health (NASDAQ: NUTX ) stock is dropping on Friday after the company announced plans for a reverse split of its shares. Nutex Health intends to enact a one-for-15 reverse stock split before markets open on April 10.

Why Is Nutex Health (NUTX) Stock Down 13% Today?

HOUSTON , April 5, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), today announced a 1-for-15 reverse stock split of its common stock effective with the market opening on Tuesday April 10, 2024.  The reverse stock split will take legal effect at 11:59pm Eastern Time on April 9, 2024, and the Company's common stock will open for trading on The Nasdaq Capital Market on April 10, 2024 on a post-split basis, under the existing ticker symbol "NUTX" but with new CUSIP number 67079U207.

News for Nutex Health Inc Stock (NUTX)